Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
MEDICAL AND NURSING CLINICS FOR THE FOLLOW-UP OF PATIENTS AFTER HOSPITALIZATION FOR ACUTE CORONARY SYNDROME: RESULTS OF THE PILOT PHASE OF THE ‘DIMISSIONI ACCOMPAGNATE (DIMACC)’ PROJECT
Anno:
2025
Background: The first year after an admission for an Acute Coronary Syndrome (ACS) is the most critical time with the highest incidence of deaths and hospital readmissions. To improve the first-year follow-up after discharge of patients admitted to our ICCU (Intensive Cardiac Care Unit) and Cardiology ward for ACS…
Leggi di più
DISCHARGE MEDICAL TREATMENT IMPLEMENTATION IN PATIENTS ADMITTED FOR AHF: PRELIMINARY DATA FROM THE BRING-UP3 HF STUDY
Anno:
2025
Background: Recent ESC guidelines introduced a new treatment paradigm for HFrEF, with a novel four pillar therapeutic approach comprising ACE-I/ARBs/ARNIs, Beta-blockers, MRAs, and SGLT2i. Furthermore, these guidelines for the first time give a Class IA recommendation for Empagliflozin and Dapagliflozin in HFmrEF and HFpEF. Evaluation of transferability of RCTs…
Leggi di più
SURGICAL OUTCOMES AND SEX DIFFERENCES IN CORONARY ARTERY BYPASS GRAFT SURGERY.
Anno:
2025
Aim. Coronary artery bypass grafting (CABG) is the most commonly performed cardiac surgery globally. The aim of the study is to investigate outcome of CABG according to participant sex in the real word. Methods. We retrospective analysed 20337 CABG operations performed in an Italian Region, Lazio, using a regional administrative dataset. Results. Between…
Leggi di più
IMPACT OF THE CARDIOPLEGIC SOLUTION ON HEART TRASPLANTATION: LONG-TERM RESULTS
Anno:
2025
Objective: The ideal method of myocardial protection for preservation of the donor heart has not yet been fully defined. We analyzed our long-term experience with heart transplantation (Htx) utilizing three different  cardioplegic solutions. Methods: During a 20-year period (2002-2022), 538 adult individuals underwent isolated Htx at our institution.  To minimize the effect…
Leggi di più
Impact of Training on Collaboration Between Cardiology and Palliative Care to Improve Quality of Life in Heart Failure Patients
Anno:
2025
Despite advances in medical therapies, many patients with heart failure continue to suffer from debilitating symptoms that profoundly affect their quality of life. For this reason, palliative care, traditionally reserved for terminal oncological diseases, is becoming a complementary strategy for patients with heart failure. Palliative care offers a comprehensive, multidisciplinary…
Leggi di più
TRANSTHYRETIN CARDIAC AMYLOIDOSIS AND AORTIC STENOSIS: WHEN TO SUSPECT THE COEXISTENCE
Anno:
2025
Degenerative aortic stenosis is the most common valvular heart disease and can cause severe concentric remodeling, diastolic dysfunction, and atrial fibrillation. These manifestations are also observed in wild-type transthyretin cardiac amyloidosis (TTR-CA), a restrictive cardiomyopathy with a poor prognosis. Studies have considered the coexistence of TTR-CA and low-flow, low-gradient…
Leggi di più
Suppressive Antibiotic Therapy: New Frontiers in the Management of High Surgical Risk Infective Endocarditis
Anno:
2025
Background and aim Suppressive antibiotic therapy (SAT) is a palliative, non-curative approach for managing infective endocarditis (IE) in selected patients. This retrospective observational descriptive study aimed to evaluate the efficacy and safety of SAT in IE patients ineligible for cardiac surgery. Methods We analyzed 14 IE patients treated with SAT between…
Leggi di più
The future of lowering triglycerides therapy in secondary cardiovascular prevention: insights from the JET-LDL Registry
Anno:
2025
Rational Hypertriglyceridemia is a common finding in patients with coronary artery disease (CAD), contributing to the residual cardiovascular risk in this population. In CAD patients with persistently elevated triglycerides levels despite lipid lowering therapies, a treatment with icosapent ethyl (IPE), compared to placebo, significantly lowered the risk of ischemic…
Leggi di più
MEDICAL AND NURSING CLINICS FOR THE FOLLOW-UP OF PATIENTS AFTER HOSPITALIZATION FOR ACUTE HEART FAILURE: RESULTS OF THE PILOT PHASE OF THE ‘DIMISSIONI ACCOMPAGNATE (DIMACC)’ PROJECT
Anno:
2025
Background: the first year after an admission for an Acute Heart Failure (AHF) is the most critical time with the highest incidence of deaths and hospital readmissions. To improve the first-year follow-up after discharge of patients admitted to our ICCU (Intensive Cardiac Care Unit) and Cardiology ward for AHF…
Leggi di più
Clinical Outcomes of Axillary-Implanted Impella 5.0/5.5 for Ischemic Cardiogenic Shock: A Retrospective Single-Center Cohort Preliminary Analysis
Anno:
2025
Background: cardiogenic shock (CS) remains a major complication of acute myocardial infarction (AMI), contributing significantly to morbidity and mortality. Temporary mechanical circulatory support (t-MCS) has gained prominence in CS management, also serving as a bridge during high-risk percutaneous coronary interventions (PCI). While the DanGer Shock Trial demonstrated the superiority of…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram